Vortioxetine (CAS 508233-74-7) is a structurally complex serotonin modulator featuring a 1,2,3,4-tetrahydroisoquinoline core linked via a sulfide bridge to a substituted benzene ring, with a piperazine side chain. Its molecular architecture includes a chiral sulfide center and aromatic heterocycles, conferring stereochemical and electronic specificity. As the parent drug, it serves as the primary pharmacophore in serotonin reuptake inhibition. This compound functions as an HPLC reference standard for quantitative analysis of serotonin modulating agents in pharmaceutical formulations.
On RequestCC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C
InChI=1S/C18H22N2S/c1-14-7-8-17(15(2)13-14)21-18-6-4-3-5-16(18)20-11-9-19-10-12-20/h3-8,13,19H,9-12H2,1-2H3
YQNWZWMKLDQSAC-UHFFFAOYSA-N